https://www.selleckchem.com/products/TWS119.html
Alzheimer Disease (AD) is a neurodegenerative disease characterized by two neuropathological hallmarks extracellular deposition of amyloid plaques and intracellular neurofibrillary tangles. Current treatment for AD (donepezil, galantamine, rivastigmine and memantine) is only symptomatic and has modest benefits. Thus, the development of drugs with the potential to change the progression of the disease has been a priority. Therapies targeting amyloid β have been the focus for almost 30 years. However, highly promising drugs recently failed
Мне нравится
Комментарий
Перепост
